SenzaGen
Anki Malmborg Hager has extensive experience of starting life science companies originating from Lund university research and is currently CEO of PainDrainer AB. Anki served as CEO of SenzaGen from 2014 to 2019. Her past experience includes CEO of Cantargia AB, XImmune AB and Diaprost AB, and before that, Investment Director at LU Bioscience AB and VP Business Development at Alligator Bioscience AB.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SenzaGen
SenzaGen is a Swedish in vitro test lab company which offers animal-free testing of chemical compounds using genomics-based methodology for immunotoxicological assays. Its proprietary lead product family, GARD, potentially replaces the need for animal testing in the cosmetic, chemical and pharmaceutical industries.